Posts
Disposable syringes are designed for one-time use and is discarded in order to prevent the spreading of infection. It can be defined as a sterile cylindrical medical instrument with a hollow needle at the end. This device act as a pump that easily draws drugs from vials and delivers these drugs to the body. A syringe is used to deliver injectable drugs in the body through an intravenous route.
The growing use of injectable drugs across the healthcare sector
is predominantly fueling the market growth of disposable syringes. The rise in
global healthcare expenditure is another key factor propelling the market
growth of disposable
syringes. According to the World Health Organization, global spending on
health was US$ 7.8 trillion in 2017 or about 10% of GDP and $1,080 per capita –
up from US$ 7.6 trillion in 2016. Moreover, the growing demand for
self-injection devices & long-acting formulations is again propelling the
market growth. Increasing spending on R&D of new drugs development coupled
with the growing demand for biologics will further favor the market growth of
disposable syringes. Furthermore, growing concerns regarding needle stick
injuries and accidental infections are also expected to bolster the market
growth of disposable syringes.
From the geographical point of view, North America is expected to
gain significant growth over the forecast period and this is attributed to the
high prevalence of the chronic disease in the region. According to the National
Health Council, chronic diseases affect approximately 133 million Americans,
representing more than 40% of the total population of this country. By 2020,
that number is projected to grow to an estimated 157 million, with 81 million
having multiple conditions. Moreover, more than 75% of all health care costs
are due to chronic conditions.
Key Developments:
1. In October
2019, BD (Becton, Dickinson, and Company) has launched the BD Intevi 1mL
two-step disposable autoinjector, a device combining autoinjector and
pre-fillable syringe in one integrated system. BD Intevia disposable
autoinjector is a two-step push-on-skin device that is designed to effectively
and safely inject a variety of drugs of different viscosities up to 35cP and
different fill volumes up to 1mL.
2. In August
2019, Morimoto Pharma has launched the new prefilled syringe product, the
Morimoto S.A.F.E. Syringe Kit ™ (Smart Accident prevention, Fast & Easy).
3. In September 2019, Hikma Pharmaceuticals PLC (Hikma, Group) has launched a new prefilled syringe capability in the US through its affiliate, Hikma Pharmaceuticals USA Inc.
No comments:
Post a Comment